 |
市场调查报告书
商品编码
1749306
NPS+(美国) - 干癣性关节炎NPS+ (US) - Psoriatic Arthritis |
||||||
美国风湿病医师在治疗干癣性关节炎方面有很多选择。然而，有些药物的忠诚度和满意度明显高于其他药物。这是为什么呢？影响医师选择的关键因素有哪些？各领导品牌与竞争对手相比如何？本报告将带您深入了解美国领先的干癣性关节炎药物。
主要的问题:
- 1.不同品牌的净推荐值 (NPS) 如何比较？
- 2.医师对特定品牌的忠诚度如何？
- 3.哪些品牌讯息能引起医师的共鸣？
- 4.影响医师药物选择的关键因素有哪些？
- 5.领先品牌的市占率是多少？
- 6.各主要品牌相对于其竞争对手的定位为何？
- 7.哪些品牌因为品牌满意度低而面临较高的转换风险？
领导品牌:
|
|
|
调查手法:
FirstView 报告是基于对透过 LiMATM 选出的医生进行的定量调查。 LiMATM 是全球最大的医生资料库，拥有超过 300 万名註册医生。所有医生均根据严格的筛选标准精心挑选，以确保收集到的见解具有相关性、可靠性，并准确反映第一线医务人员的真实意见和经验。调查结果以直观易懂的图表形式呈现，方便快速理解和分析。凭藉 LiMA 广泛的覆盖率和精准度，FirstView 报告提供无与伦比的数据驱动洞察，协助在瞬息万变的医疗保健市场中做出策略决策。
本报告特性：
FirstWord Reports 是值得信赖的行业领导者，专注于製药业，为生物製药专业人士和决策者提供深入可行的洞察。我们深厚的行业知识提供相关且有价值的信息，以识别新兴趋势并有效应对复杂课题。我们的报告以广泛的研究以及来自领先专家和关键意见领袖 (KOL) 的独立中立分析为后盾，确保了高度的准确性和可靠性。我们的报告还提供全面的市场趋势视角，包括独家访谈和数据，以及持续的市场监测。 FirstWord Reports 涵盖医生洞察（KOL 观点和定量调查结果）以及医疗事务、数位健康、销售和行销以及 40 多个疾病领域的市场准入等领域的行业专家观点。
There are various options available to US rheumatologists treating psoriatic arthritis. Clearly, some of these options achieve greater levels of loyalty and satisfaction than others, but why? What are the key factors driving physician choice, and how does each of the leading brands compare to its competitors? Gain insights into leading psoriatic arthritis therapies in the US.
Key Questions Answered:
- 1. How do NPS scores by brand compare?
- 2. How loyal are physicians to specific brands?
- 3. What brand messages resonate with physicians?
- 4. What are the key factors driving physician choice?
- 5. What is the market share of leading brands?
- 6. How does each of the leading brands compare to its competitors?
- 7. Which brands are vulnerable to switching due to low brand satisfaction?
Key Brands:
|
|
|
Methodology:
FirstView reports are developed from quantitative surveys conducted with physicians selected through LiMATM, the world's largest physician directory, containing over 3 million vetted and verified physicians. Each physician is carefully chosen based on strict screening criteria to ensure the insights gathered are both relevant and reliable, reflecting the true sentiments and experiences of leading medical professionals. The findings are presented in a series of easy-to-interpret charts, enabling you to quickly grasp and analyze the data. By leveraging the vast reach and precision of LiMATM, FirstView Reports provide unparalleled, data-driven insights to guide your strategic planning and help you stay ahead in a fast-evolving healthcare landscape.
What makes our reports different?
FirstWord Reports, a trusted industry leader with an exclusive focus on the pharmaceutical sector, delivers in-depth, actionable insights for biopharma professionals and decision-makers. Our deep industry knowledge enables us to provide relevant and valuable insights that help you identify emerging trends and navigate complex challenges effectively. Backed by extensive research and independent, impartial insights from leading experts and KOLs, our reports deliver the accuracy and reliability you need. With exclusive access to interviews and data unavailable elsewhere, along with ongoing market monitoring, we give you a comprehensive view of market dynamics. Covering over 40 dynamic disease areas and providing physician intelligence, including KOL insights and quantitative physician surveys, as well as industry expert views on issues in medical affairs, digital health, sales & marketing, market access, and other areas, our reports empower you to make smarter, data-driven decisions and maintain a competitive edge in a fast-moving industry.
